Introduction: No controlled data are available about the longterm evolution of patients (p) on isolated dual nucleoside/ nucleotide analogue (NA) antiretroviral therapy, although this phenomenon still exists in daily clinical practice, notwithstanding that antiretroviral guidelines did not include these regimens since 1997 due to their demonstrated suboptimal potency.